logo
ResearchBunny Logo
Abstract
This study investigated the role of CXCL12 in breast cancer using integrative multi-omics analyses. High CXCL12 expression was associated with prolonged survival. A prognostic signature was built using 11 CXCL12-related genes (VAT1L, TMEM92, SDC1, RORB, PCSK9, NRN1, NACAD, JPH3, GJA1, BMP8B, and ADAMTS2), which effectively predicted patient outcomes. High-risk patients showed increased M2-like macrophage infiltration and different drug sensitivities. The study suggests CXCL12-related biomarkers could guide breast cancer diagnosis and treatment.
Publisher
Frontiers in Immunology
Published On
Jul 26, 2023
Authors
Zhi-Jie Gao, Zhou Fang, Jing-Ping Yuan, Sheng-Rong Sun, Bei Li
Tags
CXCL12
breast cancer
prognostic signature
multi-omics
macrophage infiltration
biomarkers
patient outcomes
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs—just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny